These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22411881)

  • 1. Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies.
    Hsu J; Zinsou C; Parkhurst J; N'Dour M; Foyet L; Mueller DH
    Health Policy Plan; 2013 Jan; 28(1):20-9. PubMed ID: 22411881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness.
    Johnson-Masotti AP; Pinkerton SD; Kelly JA; Stevenson LY
    AIDS Care; 2000 Jun; 12(3):321-32. PubMed ID: 10928210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural interventions to prevent HIV/sexually transmitted disease: are they cost-effective for women in the southern United States?
    Cohen DA; Wu SY; Farley TA
    Sex Transm Dis; 2006 Jul; 33(7 Suppl):S46-9. PubMed ID: 16794555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cost-effectiveness of the components of a behavior change communication campaign on HIV/AIDS in North India.
    Sood S; Nambiar D
    J Health Commun; 2006; 11 Suppl 2():143-62. PubMed ID: 17148103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
    Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
    J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.
    Dew A; Khan S; Babinski C; Michel N; Heffernan M; Stephan S; Jordan N; Jovanovic B; Carney P; Bergan R
    Clin Trials; 2013 Apr; 10(2):292-9. PubMed ID: 23321266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-method use among an ethnically diverse group of women at risk of HIV infection.
    Riehman KS; Sly DF; Soler H; Eberstein IW; Quadagno D; Harrison DF
    Fam Plann Perspect; 1998; 30(5):212-7. PubMed ID: 9782043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the effectiveness of targeted interventions.
    Hassig S
    Netw Res Triangle Park N C; 1991 Jun; 12(1):21-3. PubMed ID: 12316889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual behaviour and HIV knowledge among adolescent boys in Zimbabwe.
    Campbell B; Mbizvo MT
    Cent Afr J Med; 1994 Sep; 40(9):245-50. PubMed ID: 7834713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of HIV prevention strategies in developing countries.
    Söderlund N; Lavis J; Broomberg J; Mills A
    Bull World Health Organ; 1993; 71(5):595-604. PubMed ID: 8261563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of HIV prevention programs.
    Holtgrave DR; Qualls NL; Graham JD
    Annu Rev Public Health; 1996; 17():467-88. PubMed ID: 8724236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India.
    Fung IC; Guinness L; Vickerman P; Watts C; Vannela G; Vadhvana J; Foss AM; Malodia L; Gandhi M; Jani G
    BMC Public Health; 2007 Aug; 7():195. PubMed ID: 17683595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa.
    Hutton G; Wyss K; N'Diékhor Y
    Int J Health Plann Manage; 2003; 18(2):117-36. PubMed ID: 12841152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review.
    Bozzani FM; Terris-Prestholt F; Quaife M; Gafos M; Indravudh PP; Giddings R; Medley GF; Malhotra S; Torres-Rueda S
    Pharmacoeconomics; 2023 May; 41(5):467-480. PubMed ID: 36529838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the cost-effectiveness of HIV prevention interventions.
    Cohen DA; Wu SY; Farley TA
    J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1404-14. PubMed ID: 15483470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on cost effectiveness of HIV prevention interventions in the United States.
    Huang YL; Lasry A; Hutchinson AB; Sansom SL
    Appl Health Econ Health Policy; 2015 Apr; 13(2):149-56. PubMed ID: 25536927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Condom distribution: a cost-utility analysis.
    Bedimo AL; Pinkerton SD; Cohen DA; Gray B; Farley TA
    Int J STD AIDS; 2002 Jun; 13(6):384-92. PubMed ID: 12015012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Cost Analysis of Four Interventions to Prevent HIV Transmission in Bandung, Indonesia.
    Verstraaten EJM; Beeren FMM; Janssen JLC; Kemper S; Siregar AYM; Tromp N; Baltussen R
    Acta Med Indones; 2017 Jul; 49(3):236-242. PubMed ID: 29093234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.